Follow
Gary Hannon
Gary Hannon
University of Rochester Medical Center
Verified email at tcd.ie
Title
Cited by
Cited by
Year
Measuring particle size distribution and mass concentration of nanoplastics and microplastics: addressing some analytical challenges in the sub-micron size range
F Caputo, R Vogel, J Savage, G Vella, A Law, G Della Camera, G Hannon, ...
Journal of Colloid and Interface Science 588, 401-417, 2021
1182021
Immunotoxicity considerations for next generation cancer nanomedicines
G Hannon, J Lysaght, NJ Liptrott, A Prina‐Mello
Advanced Science 6 (19), 1900133, 2019
672019
The Effects of Localized Heat on the Hallmarks of Cancer
G Hannon, FL Tansi, I Hilger, A Prina-Mello
Advanced Therapeutics 2000267, 2021
312021
Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing
G Hannon, A Prina-Mello
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 2021
172021
Comparing the effects of intracellular and extracellular magnetic hyperthermia on the viability of BxPC-3 cells
G Hannon, A Bogdanska, Y Volkov, A Prina-Mello
Nanomaterials 2020 (10), 593, 2020
132020
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models
J Ye, NW Gavras, DC Keeley, AL Hughson, G Hannon, TG Vrooman, ...
Journal for ImmunoTherapy of Cancer 11 (5), e006842, 2023
52023
Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
G Hannon, ML Lesch, SA Gerber
Internation Journal of Molecular Sciences 24 (7359), 2023
42023
Thermal Ablation in Pancreatic Cancer: A Scoping Review of Clinical Studies
W Farmer, G Hannon, S Ghosh, A Prina-Mello
Frontiers in Oncology, 6710, 2022
42022
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy
TP Uccello, ML Lesch, SA Kintzel, LB Gradzewicz, L Lamrous, SP Murphy, ...
Cell Death & Disease 14 (7), 470, 2023
32023
Immunotoxicity and safety considerations for iron oxide nanoparticles
G Hannon, MA Tutty, A Prina-Mello
Clinical Applications of Magnetic Nanoparticles, 273-288, 2018
32018
Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer
AL Hughson, G Hannon, NA Salama, TG Vrooman, CA Stockwell, ...
bioRxiv, 2023.10. 30.564833, 2023
2023
Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats
G Hannon, A Bogdanska, A Keogh, SP Finn, OL Gobbo, A Prina-Mello
Nanotoxicology 17 (8-9), 562-580, 2023
2023
Testing the Effects of Magnetic Hyperthermia in 2D Cell Culture
G Hannon, A Prina-Mello
Cancer Cell Culture 2645, 251-261, 2023
2023
Assessing the potential of iron oxide nanoparticles to treat cancer through magnetic hyperthermia
G Hannon
The system can't perform the operation now. Try again later.
Articles 1–14